1
|
Eveque-Mourroux MR, Rocha B, Barré FPY, Heeren RMA, Cillero-Pastor B. Spatially resolved proteomics in osteoarthritis: State of the art and new perspectives. J Proteomics 2020; 215:103637. [PMID: 31926309 DOI: 10.1016/j.jprot.2020.103637] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2019] [Revised: 12/07/2019] [Accepted: 01/05/2020] [Indexed: 01/18/2023]
Abstract
Osteoarthritis (OA) is one of the most common diseases worldwide caused by chronic degeneration of the joints. Its high prevalence and the involvement of several tissues define OA as a highly heterogeneous disease. New biological markers to evaluate the progression of the pathology and improve its prognosis are needed. Among all the different -omic strategies applied to OA, solution phase bottom-up proteomics has made an extensive contribution to the field of biomarker research. However, new technologies for protein analysis should be considered for a better understanding of the disease. This review focuses on complementary proteomic methodologies and new technologies for translational research of OA and other rheumatic pathologies, especially mass spectrometry imaging and protein imaging methods not applied by the OA community yet.
Collapse
Affiliation(s)
- M R Eveque-Mourroux
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University, Universiteitssingel 50, 6229, ER, Maastricht, the Netherlands
| | - B Rocha
- Proteomics Group-ProteoRed/ISCIII, Grupo de Investigación de Reumatología (GIR), INIBIC - Hospital Universitario de A Coruña, A Coruña, Spain
| | - F P Y Barré
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University, Universiteitssingel 50, 6229, ER, Maastricht, the Netherlands
| | - R M A Heeren
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University, Universiteitssingel 50, 6229, ER, Maastricht, the Netherlands
| | - B Cillero-Pastor
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University, Universiteitssingel 50, 6229, ER, Maastricht, the Netherlands.
| |
Collapse
|
2
|
Barré FPY, Paine MRL, Flinders B, Trevitt AJ, Kelly PD, Ait-Belkacem R, Garcia JP, Creemers LB, Stauber J, Vreeken RJ, Cillero-Pastor B, Ellis SR, Heeren RMA. Enhanced Sensitivity Using MALDI Imaging Coupled with Laser Postionization (MALDI-2) for Pharmaceutical Research. Anal Chem 2019; 91:10840-10848. [PMID: 31355633 PMCID: PMC6706868 DOI: 10.1021/acs.analchem.9b02495] [Citation(s) in RCA: 59] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Visualizing the distributions of drugs and their metabolites is one of the key emerging application areas of matrix-assisted laser desorption/ionization-mass spectrometry imaging (MALDI-MSI) within pharmaceutical research. The success of a given MALDI-MSI experiment is ultimately determined by the ionization efficiency of the compounds of interest, which in many cases are too low to enable detection at relevant concentrations. In this work we have taken steps to address this challenge via the first application of laser-postionisation coupled with MALDI (so-called MALDI-2) to the analysis and imaging of pharmaceutical compounds. We demonstrate that MALDI-2 increased the signal intensities for 7 out of the 10 drug compounds analyzed by up to 2 orders of magnitude compared to conventional MALDI analysis. This gain in sensitivity enabled the distributions of drug compounds in both human cartilage and dog liver tissue to be visualized using MALDI-2, whereas little-to-no signal from tissue was obtained using conventional MALDI. This work demonstrates the vast potential of MALDI-2-MSI in pharmaceutical research and drug development and provides a valuable tool to broaden the application areas of MSI. Finally, in an effort to understand the ionization mechanism, we provide the first evidence that the preferential formation of [M + H]+ ions with MALDI-2 has no obvious correlation with the gas-phase proton affinity values of the analyte molecules, suggesting, as with MALDI, the occurrence of complex and yet to be elucidated ionization phenomena.
Collapse
Affiliation(s)
- Florian P Y Barré
- The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands
| | - Martin R L Paine
- The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands
| | - Bryn Flinders
- The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands
| | - Adam J Trevitt
- School of Chemistry , University of Wollongong , Wollongong , Australia
| | - Patrick D Kelly
- School of Chemistry , University of Wollongong , Wollongong , Australia
| | | | - João P Garcia
- University Medical Centre (UMC) Utrecht , Department of Orthopedics , Heidelberglaan 100 , 3584 CX Utrecht , The Netherlands
| | - Laura B Creemers
- University Medical Centre (UMC) Utrecht , Department of Orthopedics , Heidelberglaan 100 , 3584 CX Utrecht , The Netherlands
| | | | - Rob J Vreeken
- The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands.,Discovery Sciences , Janssen Research and Development , Beerse , Belgium
| | - Berta Cillero-Pastor
- The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands
| | - Shane R Ellis
- The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands
| | - Ron M A Heeren
- The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands
| |
Collapse
|
3
|
Barré FPY, Claes BSR, Dewez F, Peutz-Kootstra C, Munch-Petersen HF, Grønbæk K, Lund AH, Heeren RMA, Côme C, Cillero-Pastor B. Specific Lipid and Metabolic Profiles of R-CHOP-Resistant Diffuse Large B-Cell Lymphoma Elucidated by Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging and in Vivo Imaging. Anal Chem 2018; 90:14198-14206. [PMID: 30422637 PMCID: PMC6328237 DOI: 10.1021/acs.analchem.8b02910] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
![]()
Diffuse
large B-cell lymphoma (DLBCL) is the most common B-cell
non-Hodgkin lymphoma. To treat this aggressive disease, R-CHOP, a
combination of immunotherapy (R; rituximab) and chemotherapy (CHOP;
cyclophosphamide, doxorubicin, vincristine, and prednisone), remains
the most commonly used regimen for newly diagnosed DLBCLs. However,
up to one-third of patients ultimately becomes refractory to initial
therapy or relapses after treatment, and the high mortality rate highlights
the urgent need for novel therapeutic approaches based upon selective
molecular targets. In order to understand the molecular mechanisms
underlying relapsed DLBCL, we studied differences in the lipid and
metabolic composition of nontreated and R-CHOP-resistant tumors, using
a combination of in vivo DLBCL xenograft models and mass spectrometry
imaging. Together, these techniques provide information regarding
analyte composition and molecular distributions of therapy-resistant
and sensitive areas. We found specific lipid and metabolic profiles
for R-CHOP-resistant tumors, such as a higher presence of phosphatidylinositol
and sphingomyelin fragments. In addition, we investigated intratumor
heterogeneity and identified specific lipid markers of viable and
necrotic areas. Furthermore, we could monitor metabolic changes and
found reduced adenosine triphosphate and increased adenosine monophosphate
in the R-CHOP-resistant tumors. This work highlights the power of
combining in vivo imaging and MSI to track molecular signatures in
DLBCL, which has potential application for other diseases.
Collapse
Affiliation(s)
- Florian P Y Barré
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , 6229 ER Maastricht , The Netherlands
| | - Britt S R Claes
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , 6229 ER Maastricht , The Netherlands
| | - Frédéric Dewez
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , 6229 ER Maastricht , The Netherlands
| | - Carine Peutz-Kootstra
- Department of Pathology , Maastricht University Medical Center, Cardiovascular Research Institute Maastricht , 6229 HX Maastricht , The Netherlands
| | - Helga F Munch-Petersen
- Department of Haematology and Department of Pathology , Rigshospitalet , 2100 Copenhagen , Denmark
| | - Kirsten Grønbæk
- Epigenomlaboratoriet, Rigshospitalet Dept. 3733 , Bartholin Institute , Copenhagen Biocenter, 2200 Copenhagen , Denmark.,Biotech Research and Innovation Centre (BRIC) , University of Copenhagen , 2200 Copenhagen , Denmark
| | - Anders H Lund
- Biotech Research and Innovation Centre (BRIC) , University of Copenhagen , 2200 Copenhagen , Denmark
| | - Ron M A Heeren
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , 6229 ER Maastricht , The Netherlands
| | - Christophe Côme
- Epigenomlaboratoriet, Rigshospitalet Dept. 3733 , Bartholin Institute , Copenhagen Biocenter, 2200 Copenhagen , Denmark.,Biotech Research and Innovation Centre (BRIC) , University of Copenhagen , 2200 Copenhagen , Denmark
| | - Berta Cillero-Pastor
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , 6229 ER Maastricht , The Netherlands
| |
Collapse
|
4
|
Gussenhoven R, Ophelders DRMG, Kemp MW, Payne MS, Spiller OB, Beeton ML, Stock SJ, Cillero-Pastor B, Barré FPY, Heeren RMA, Kessels L, Stevens B, Rutten BP, Kallapur SG, Jobe AH, Kramer BW, Wolfs TGAM. The Paradoxical Effects of Chronic Intra-Amniotic Ureaplasma parvum Exposure on Ovine Fetal Brain Development. Dev Neurosci 2017; 39:472-486. [PMID: 28848098 DOI: 10.1159/000479021] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2017] [Accepted: 06/24/2017] [Indexed: 01/23/2023] Open
Abstract
Chorioamnionitis is associated with adverse neurodevelopmental outcomes in preterm infants. Ureaplasma spp. are the microorganisms most frequently isolated from the amniotic fluid of women diagnosed with chorioamnionitis. However, controversy remains concerning the role of Ureaplasma spp. in the pathogenesis of neonatal brain injury. We hypothesize that reexposure to an inflammatory trigger during the perinatal period might be responsible for the variation in brain outcomes of preterms following Ureaplasma-driven chorioamnionitis. To investigate these clinical scenarios, we performed a detailed multimodal study in which ovine neurodevelopmental outcomes were assessed following chronic intra-amniotic Ureaplasma parvum (UP) infection either alone or combined with subsequent lipopolysaccharide (LPS) exposure. We show that chronic intra-amniotic UP exposure during the second trimester provoked a decrease in astrocytes, increased oligodendrocyte numbers, and elevated 5-methylcytosine levels. In contrast, short-term LPS exposure before preterm birth induced increased microglial activation, myelin loss, elevation of 5-hydroxymethylcytosine levels, and lipid profile changes. These LPS-induced changes were prevented by chronic preexposure to UP (preconditioning). These data indicate that chronic UP exposure has dual effects on preterm brain development in utero. On the one hand, prolonged UP exposure causes detrimental cerebral changes that may predispose to adverse postnatal clinical outcomes. On the other, chronic intra-amniotic UP exposure preconditions the brain against a second inflammatory hit. This study demonstrates that microbial interactions and the timing and duration of the inflammatory insults determine the effects on the fetal brain. Therefore, this study helps to understand the complex and diverse postnatal neurological outcomes following UP driven chorioamnionitis.
Collapse
Affiliation(s)
- Ruth Gussenhoven
- Department of Pediatrics, Maastricht University Medical Center, Maastricht, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Barré FPY, Flinders B, Garcia JP, Jansen I, Huizing LRS, Porta T, Creemers LB, Heeren RMA, Cillero-Pastor B. Derivatization Strategies for the Detection of Triamcinolone Acetonide in Cartilage by Using Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging. Anal Chem 2016; 88:12051-12059. [PMID: 28193015 DOI: 10.1021/acs.analchem.6b02491] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Osteoarthritis (OA), characterized by degeneration of the cartilaginous tissue in articular joints, severely impairs mobility in many people worldwide. The degeneration is thought to be mediated by inflammatory processes occurring in the tissue of the joint, including the cartilage. Intra-articular administered triamcinolone acetonide (TAA) is one of the drug treatments employed to ameliorate the inflammation and pain that characterizes OA. However, the penetration and distribution of TAA into the avascular cartilage is not well understood. We employed matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI), which has been previously used to directly monitor the distribution of drugs in biological tissues, to evaluate the distribution of TAA in human cartilage after in vitro incubation. Unfortunately, TAA is not easily ionized by regular electrospray ionization (ESI) or MALDI. To overcome this problem, we developed an on-tissue derivatization method with Girard's reagent T (GirT) in human incubated cartilage being able to study its distribution and quantify the drug abundance (up to 3.3 ng/μL). Our results demonstrate the depth of penetration of a corticosteroid drug in human OA cartilage using MALDI-MSI.
Collapse
Affiliation(s)
- Florian P Y Barré
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University , Universiteitssingel 50, 6229 ER Maastricht, The Netherlands
| | - Bryn Flinders
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University , Universiteitssingel 50, 6229 ER Maastricht, The Netherlands
| | - João P Garcia
- University Medical Centre (UMC) Utrecht , Orthopedics Department, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
| | - Imke Jansen
- University Medical Centre (UMC) Utrecht , Orthopedics Department, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
| | - Lennart R S Huizing
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University , Universiteitssingel 50, 6229 ER Maastricht, The Netherlands
| | - Tiffany Porta
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University , Universiteitssingel 50, 6229 ER Maastricht, The Netherlands
| | - Laura B Creemers
- University Medical Centre (UMC) Utrecht , Orthopedics Department, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
| | - Ron M A Heeren
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University , Universiteitssingel 50, 6229 ER Maastricht, The Netherlands
| | - Berta Cillero-Pastor
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University , Universiteitssingel 50, 6229 ER Maastricht, The Netherlands
| |
Collapse
|